Lipocine Inc (NQ: LPCN )

1.760 USD +0.140 (+8.64%)

Official Closing Price Updated: 7:59 PM EST, Jan 19, 2021 Add to My Watchlist

Price and Volume

Volume	9,981,900
Open	1.650
Bid (Size)	1.860 (5)
Ask (Size)	1.870 (7)
Prev. Close	1.620
Today's Range	1.650 - 1.980
52wk Range	0.3000 - 2.390
Shares Outstanding	21,264,539
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Lipocine Announces USPTO Declaration Of Interference Between Lipocine And Clarus Patent Applications

January 14, 2021

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the Patent Trial and Appeal Board ("PTAB") of the United...

Lipocine Announces Positive Topline Phase 2 Results from LPCN 1144 Ongoing LiFT Study in Biopsy-Confirmed NASH Subjects

January 12, 2021

Conference Call Scheduled for 8:30 a.m. ET today

Performance

YTD	+23.08%	+23.08%
1 Month	+23.94%	+23.94%
3 Month	+29.41%	+29.41%
6 Month	+19.73%	+19.73%
1 Year	+220.06%	+220.06%

More News

Lipocine to Present at the H.C. Wainwright BioConnect 2021 Conference

January 04, 2021

Lipocine Announces Open Label Extension to Ongoing LPCN 1144 LiFT Study

December 30, 2020

Lipocine Announces Update on Jury Trial in Patent Infringement Lawsuit Against Clarus Therapeutics

December 29, 2020

Lipocine Announces Tentative Approval of TLANDO™

December 08, 2020

Lipocine Announces Deletion of Unauthorized Changes to Company's Website

December 08, 2020

Lipocine Provides New Regulatory Update on TLANDO™

December 04, 2020

Making A List Of Penny Stocks? 3 Names You Should Know, Now

December 08, 2020

5 Biotech Penny Stocks To Watch With Recent & Upcoming Events

December 06, 2020

Lipocine Announces Third Quarter 2020 Financial and Operational Results

November 10, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.